1. Home
  2. IMRN vs MI Comparison

IMRN vs MI Comparison

Compare IMRN & MI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • MI
  • Stock Information
  • Founded
  • IMRN 1994
  • MI 2009
  • Country
  • IMRN Australia
  • MI Hong Kong
  • Employees
  • IMRN N/A
  • MI N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • MI Catalog/Specialty Distribution
  • Sector
  • IMRN Health Care
  • MI Consumer Discretionary
  • Exchange
  • IMRN Nasdaq
  • MI Nasdaq
  • Market Cap
  • IMRN 9.2M
  • MI 21.7M
  • IPO Year
  • IMRN N/A
  • MI N/A
  • Fundamental
  • Price
  • IMRN $1.80
  • MI $3.56
  • Analyst Decision
  • IMRN Strong Buy
  • MI
  • Analyst Count
  • IMRN 1
  • MI 0
  • Target Price
  • IMRN $5.00
  • MI N/A
  • AVG Volume (30 Days)
  • IMRN 46.0K
  • MI 50.3K
  • Earning Date
  • IMRN 08-29-2025
  • MI 01-01-0001
  • Dividend Yield
  • IMRN N/A
  • MI N/A
  • EPS Growth
  • IMRN N/A
  • MI N/A
  • EPS
  • IMRN N/A
  • MI 1.53
  • Revenue
  • IMRN $4,777,422.00
  • MI $740,701.00
  • Revenue This Year
  • IMRN N/A
  • MI N/A
  • Revenue Next Year
  • IMRN N/A
  • MI N/A
  • P/E Ratio
  • IMRN N/A
  • MI $2.28
  • Revenue Growth
  • IMRN 48.63
  • MI N/A
  • 52 Week Low
  • IMRN $1.50
  • MI $1.57
  • 52 Week High
  • IMRN $2.87
  • MI $10.29
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 48.12
  • MI 55.05
  • Support Level
  • IMRN $1.80
  • MI $3.34
  • Resistance Level
  • IMRN $1.94
  • MI $3.88
  • Average True Range (ATR)
  • IMRN 0.08
  • MI 0.50
  • MACD
  • IMRN -0.01
  • MI -0.00
  • Stochastic Oscillator
  • IMRN 22.22
  • MI 51.95

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About MI NFT Limited

NFT Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.

Share on Social Networks: